- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Renascience Inc (4889)
The Renascience share price today is 1,345.00, view TYO 4889 stock exchange data. Track the latest Renascience share price with real-time updates on 4889 stock performance including market cap, day range, 52-week range and dividend yield. Access 4889 charts, earnings dates and analyst estimates to support your investment decisions.
1,345.00
+55.00(+4.26%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,276.00
1,349.00
52 wk Range
1,101.00
2,342.00
4889 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,276.001,349.00
52 wk Range
1,101.002,342.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4889 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
14-08-2026
EPS / Forecast
-5.95 / --
Revenue / Forecast
10M / --
Compare 4889 to Peers and Sector
Metrics to compare | 4889 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4889PeersSector | |
|---|---|---|---|---|
P/E Ratio | −61.6x | 5.9x | −0.4x | |
PEG Ratio | 0.17 | 0.03 | 0.00 | |
Price/Book | 5.6x | 1.6x | 2.6x | |
Price / LTM Sales | 272.5x | 1.7x | 3.1x | |
Upside (Analyst Target) | - | 17.7% | 48.2% | |
Fair Value Upside | Unlock | 10.1% | 6.5% | Unlock |
Renascience Inc. develops and sells pharmaceuticals, medical devices, and artificial intelligence (AI)-powered programmed medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, cutaneous angio-sarcoma, coronavirus lung injury, and interstitial lung disease associated with systemic scleroderma; RS5441, PAI-1 inhibitor for the treatment of alopecia disease that is in Phase I clinical trials; and RS8001, a water-soluble vitamin for use in the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder and menopausal disorder, which is in phase 1 clinical trials. It is also developing RS9001, a disposable ultrafine endoscope; artificial intelligence-based medical solutions; pancreatic cancer; anti-aging and longevity oral drugs (senolytics); topical medications for male pattern baldness and age-related hair loss; and diagnostic solutions. The company was incorporated in 2000 and is headquartered in Sendai, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Renascience (4889) Share Price Today?
The Renascience share price today is 1,345.00.
What is the current Renascience (4889) share price and day range?
As of 29-08-2026, the Renascience share price is 1,345.00, with a previous close of 1,290.00. The share price has ranged from 1,276.00 to 1,349.00 today, while the 52-week range spans from 1,101.00 to 2,342.00.
What Is the Renascience Market Cap?
As of today, Renascience market cap is 18.53B.
What Is Renascience's Earnings Per Share (TTM)?
The Renascience EPS (TTM) is -23.37.
When Is the Next Renascience Earnings Date?
Renascience will release its next earnings report on 05-11-2026.
From a Technical Analysis Perspective, Is 4889 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Renascience Trade On?
Renascience is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Renascience?
The stock symbol for Renascience is "4889."
How Many Times Has Renascience Stock Split?
Renascience has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.